GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » EV-to-Revenue

Abbott India (BOM:500488) EV-to-Revenue : 9.28 (As of May. 17, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abbott India EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Abbott India's enterprise value is ₹542,613 Mil. Abbott India's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹58,489 Mil. Therefore, Abbott India's EV-to-Revenue for today is 9.28.

The historical rank and industry rank for Abbott India's EV-to-Revenue or its related term are showing as below:

BOM:500488' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.49   Med: 4.5   Max: 10.9
Current: 9.28

During the past 13 years, the highest EV-to-Revenue of Abbott India was 10.90. The lowest was 1.49. And the median was 4.50.

BOM:500488's EV-to-Revenue is ranked worse than
86.65% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.415 vs BOM:500488: 9.28

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-17), Abbott India's stock price is ₹26545.40. Abbott India's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹2,752.40. Therefore, Abbott India's PS Ratio for today is 9.64.


Abbott India EV-to-Revenue Historical Data

The historical data trend for Abbott India's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India EV-to-Revenue Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.53 6.87 7.13 8.44 9.42

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.44 9.01 8.39 8.44 9.42

Competitive Comparison of Abbott India's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Abbott India's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Abbott India's EV-to-Revenue falls into.



Abbott India EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Abbott India's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=542613.021/58489.1
=9.28

Abbott India's current Enterprise Value is ₹542,613 Mil.
Abbott India's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹58,489 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott India  (BOM:500488) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Abbott India's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=26545.40/2752.396
=9.64

Abbott India's share price for today is ₹26545.40.
Abbott India's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,752.40.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott India EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Abbott India's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (BOM:500488) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines